China's cybersecurity regulator has tightened its oversight of foreign share listings of domestic companies in a move prompted by Chinese data security concerns. Although health care companies were not the target, it led LinkDoc to suspend its $211m IPO shortly after filing an application to list its shares on Nasdaq. Trading in shares had been due to start on 9 July.
LinkDoc, a leading Chinese health tech player, intended to issue 10.825 million American Depository shares in the price range $17.5-$19.5 via a listing on Nasdaq. However, the company halted its...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?